• Hereditary Disease Foundation Gala Raises $900,000 for Huntington’s Research
  • Spanish Study Explains Why Protein Loses Its Ability to Protect Nerve Cells
  • Mitochon Pharmaceuticals Allowed First Patent Securing Development of MP101
  • Canada’s ‘One Extra Push’ Campaign Aims to Raise Awareness of Huntington’s Disease
  • Researchers Identify Mechanism to Prevent Toxic Accumulation of Proteins in Mitochondria
  • Children’s National, NORD Partner to Create Rare Disease ‘Centers of Excellence’
  • Natural Compounds May Carry Therapeutical Benefits for Huntington’s
  • Plant Study Reveals Mechanism That May Explain Protein Folding in Human Disease
  • uniQure Gene Therapy Candidate Improves Motor Coordination, Survival in Huntington’s Mice, Study Shows
  • #NORDsummit – Alternatives to Large Placebo Trials, Grant Awards Among Ways FDA Supporting Rare Diseases, Chief Says
  • Molecular Interactions Study May Advance Insight into Huntington’s Disease Processes
  • #NORDsummit – Despite Criticism, Orphan Drug Act Is Working to Advance Needed Treatments, FDA Says